Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease
Growth and the Effect of Genotropin in Chronically Ill Children With Juvenile Rheumatoid Arthritis and With Crohn's Disease
Sponsor: Nationwide Children's Hospital
Terminated
PI left the institution
Other terminated trials from Nationwide Children's Hospital
This PHASE2/PHASE3 trial investigates Arthritis, Juvenile Rheumatoid and Crohn Disease and is currently terminated or withdrawn. Nationwide Children's Hospital leads this study, which shows 9 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2_PHASE3
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE2_PHASE3
▶ Show 4 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2_PHASE3
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE2_PHASE3
-
Feb 2017 — May 2018 [monthly]
Terminated PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE2_PHASE3
First recorded
Aug 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nationwide Children's Hospital
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .